Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 CAD | +0.65% | +4.76% | -13.97% |
04-11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
04-11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.97% | 84.41M | |
+0.67% | 42.4B | |
+46.17% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Biotech : Says Q4 2020 Net Loss Was $9.3 Million, to Report Clinical Biomarker/Safety Data In Breast Cancer in 2021